The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text (PDF, 948K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nathan, C. F.
Right arrow Articles by David, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nathan, C. F.
Right arrow Articles by David, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
The Journal of Experimental Medicine, Vol 137, 275-290, Copyright © 1973 by The Rockefeller University Press


ARTICLE

CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONS

Carl F. Nathan 1, Heinz G. Remold 1, and John R. David 1

1 From the Departments of Medicine, Harvard Medical School and the Robert B. Brigham Hospital, Boston, Massachusetts 02120

As reported previously, antigenically stimulated guinea pig lymphocytes elaborate a soluble factor which activates macrophages in the sense of promoting increased adherence, spreading, phagocytosis, and glucose oxidation through the hexose monophosphate pathway. Further studies on the characteristics and kinetics of this substance were carried out. The activating factor could not be distinguished from a previously characterized lymphocyte mediator, migration inhibitory factor (MIF), on the basis of Sephadex G-100 gel filtration, CsCl density gradient centrifugation, or sensitivity to neuraminidase. It was, however, shown to be distinct from two other lymphocyte mediators, chemotactic factor for macrophages and lymphotoxin. The kinetics of activation were further studied. The data suggest that the 3 day period required by macrophages to manifest a response to the activating factor consists of two stages. In the first, requiring 1–2 days, the macrophages are refractory to the influence of activating factor, but undergo changes which render them receptive. In the second, they respond to activating factor with increased cell adherence and glucose oxidation. Once macrophages have been activated, the effect persists in the absence of activating factor for 24 h. Finally, it was shown that activation in unfractionated supernatants followed the same time-course as that in more purified fractions. The data suggests that the activating factor is the same as MIF and that, in vitro, macrophages respond to this substance with migration inhibition before they become sensitive to its activating influence.

Submitted on August 4, 1972


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS